Growth inhibition of DMBA-induced rat mammary carcinomas by UK 114

被引：0

作者：

Silvia Racca

Francesco Di Carlo

Alberto Bartorelli

Benedetta Bussolati

G. Bussolati

机构：

[1] Department of Biological and Clinical Sciences,

[2] University of Turin,undefined

[3] Turin,undefined

[4] Italy,undefined

[5] ”G. Sisini” Institute,undefined

[6] University of Milan,undefined

[7] Milan,undefined

[8] Italy,undefined

[9] Department of Medical and Surgical Sciences,undefined

[10] University of Turin,undefined

[11] Turin,undefined

[12] Italy,undefined

[13] Department of Biomedical Sciences and Human Oncology,undefined

[14] University of Turin,undefined

[15] Via Santena 7,undefined

[16] I-10126 Torino,undefined

[17] Italy Tel.: (39) 11-6706505; Fax: (39) 11-6635267,undefined

来源：

Virchows Archiv | 1997年 / 431卷

关键词：

Key words Immunosurveillance; Cytotoxicity; Neoplasms; Dimethylbenzanthracene; Rats;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A perchloric acid-soluble protein extracted from goat liver and designated as UK 114 is known to be expressed over the cell membrane of (some) human cancer cell lines. This protein is antigenic, and specific antibodies elicit complement-dependent cytolysis of neoplastic target cells. In this study we demonstrate that administration of UK 114, either pure or as a crude extract (designated UK 101), inhibits the growth of mammary carcinomas induced in female Sprague-Dawley rats by dimethylbenzanthracene (DMBA). The mechanism of the tumour inhibitory activity of UK 114 is probably related to induction of immunosurveillance.

引用

页码：323 / 328

页数：5

共 50 条

[31] Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies
Yan, M
Schneider, J
Gear, R
Lu, FX
LaDow, K
Warshawsky, D
Heffelfinger, SC
PATHOBIOLOGY, 2004, 71 (05) : 253 - 260
[32] INTERSTITIAL FLUID PRESSURE IN DMBA-INDUCED RAT MAMMARY-TUMORS
WIIG, H
TVEIT, E
HULTBORN, R
REED, RK
WEISS, L
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1982, 42 (02): : 159 - 164
[33] INHIBITORY EFFECT OF ANDROGENS ON DMBA-INDUCED MAMMARY-CARCINOMA IN THE RAT
DAUVOIS, S
LI, SM
MARTEL, C
LABRIE, F
BREAST CANCER RESEARCH AND TREATMENT, 1989, 14 (03) : 299 - 306
[34] A rat cell line derived from DMBA-induced mammary carcinoma
Chow, LWC
Cheung, MNB
Loo, WTY
Guan, XY
LIFE SCIENCES, 2003, 73 (01) : 27 - 40
[35] Influence of estradiol on mammary tumor collagen solubility in DMBA-induced rat mammary tumors
Rajkumar, L
Balasubramanian, K
Arunakaran, J
Govindarajulu, P
Srinivasan, N
CELL BIOLOGY INTERNATIONAL, 2006, 30 (02) : 164 - 168
[36] ANTICARCINOGENIC EFFECTS OF ESTRIOL IN DMBA-INDUCED RAT MAMMARY-CANCER
WOTIZ, HH
MULLER, RE
CUPPLES, LA
BENNETT, M
MATURITAS, 1984, 6 (02) : 209 - 209
[37] Change in chemosensitivity of DMBA-induced rat mammary tumor after oophorectomy
Isogai, M
Kondo, K
Kitamura, N
ANTICANCER RESEARCH, 1998, 18 (2A) : 963 - 966
[38] TYROSINE PROTEIN-KINASE ACTIVITY IN THE DMBA-INDUCED RAT MAMMARY-TUMOR - INHIBITION BY QUERCETIN
LEVY, J
TEUERSTEIN, I
MARBACH, M
RADIAN, S
SHARONI, Y
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (03) : 1227 - 1233
[39] RETINOID FEEDING, HORMONE INHIBITION AND OR IMMUNE STIMULATION AND THE GENESIS OF DMBA-INDUCED RAT MAMMARY-TUMORS
DEHOOG, JV
WELSCH, CW
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 87 - 87
[40] Ospemifene inhibits the growth of DMBA-induced mammary tumors in mice.
Morello-Read, KC
Marchisano, C
Wurz, GT
DeGregorio, MW
BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S177 - S177

← 1 2 3 4 5 →